Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-18

FDA Approved: RASAGILINE — Original Application (Carnegie Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved Carnegie Pharmaceuticals' original application for Rasagiline (rasagiline mesylate), a generic monoamine oxidase-B inhibitor used to treat Park…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rasagiline mesylate (RASAGILINE MESYLATE)

Snippet

ORIG AP for RASAGILINE (RASAGILINE MESYLATE)